Global Transcriptomics Market 2016-2020

Overview of the transcriptomics market

Transcriptomics involves the collection and analysis of transcriptomes of different types of cells or tissues present in an organism. A transcriptome characterizes the set of all RNA molecules, which is a part of the genetic code. Transcriptomics has extensive applications in molecular genetics, leading to its augmented demand during the predicted period. The need for specific transcriptomic solutions has resulted in massive investments to develop new technologies, such as microRNA technology, RNAi technology, NGS technology, and RT-PCR technology. These new-age technologies allow researchers to analyze the transcriptional activity of different organisms with higher precision and accuracy. Moreover, advances in transcriptomics technology fuel the demand for innovative and improved data analysis tools and services that can handle huge amounts of transcriptomics data and provide accurate results. According to the market research analysts at Technavio, the global transcriptomics market is expected to grow exponentially at a CAGR of more than 14% over the forecast period.

The increasing prevalence of cardiovascular and CNS disorders and cancer has led to an augmented demand for advanced tools and systems for diagnostics and drug discovery. Gene expression patterns and gene regulation mechanisms, which trigger the functioning and production of proteins can be studied using transcriptomics, and the therapeutic target can be identified more accurately. The increasing demand for personalized medicines and transcriptomics technologies and continuous improvements in healthcare infrastructures are encouraging drug discovery and research. Several biotechnology companies, such as F. Hoffmann-La Roche, Illumina, and Abbott Laboratories are investing heavily in medical research to develop reliable tools and services, which is likely to have a positive impact on the market.

Competitive landscape and key vendors

The global transcriptomics market is characterized by the presence of several international and regional vendors. The market is growing steadily with an increase in the number of applications that use transcriptomics testing. The vendors compete on various factors such as price, availability, brand, and variety, where price is set to become a major cause of competition as it enables players to gain an edge in the market. The need for large investments and rapid product innovations are major barriers for the entry of new players. Therefore, vendors must expand geographically and revive domestic demand to achieve sustained growth over time.

Key vendors in this market are -

• Agilent Technologies
• Illumina
• Roche Diagnostics
• Thermo Fisher Scientific

Other prominent vendors in the market include Beckman Coulter, Becton, Dickinson and Company, Biological Industries, bioMérieux, Bio-Rad Laboratories, Cepheid, Clontech Laboratories, Cytognomix, Edico Genome, Eppendorf, Fluidigm, GE Healthcare, Harvard Bioscience, Kapa Biosystems, Leica Biosystems, Maxim Biotech, Molecular Devices, Oxford Gene Technology, PerkinElmer, Promega, Qiagen, RainDance Technologies, Siemens Healthcare, and Sigma-Aldrich. 

Product segmentation and analysis of the transcriptomics market

• Transcriptomics consumables
• Transcriptomics instruments

During 2015, the transcriptomics consumables segment dominated the market and accounted for more than 56% of the market shares in terms of revenue. The growth of this segment is mainly because of the repeated purchase of reagents, assays, and enzymes for conducting tests. Most of the diagnostic centers that need to carry out a large number of tests for chronic diseases acquire equipment on rent due to high costs. However, they purchase the reagents in large quantities, thus providing revenue opportunities for vendors.

Geographical segmentation and analysis of the transcriptomics market

• Americas
• APAC
• EMEA

In terms of geography, the Americas led the global transcriptomics market and is expected to hold more than 50% of the revenue market shares by 2020. The growth of this market in the Americas is attributed to the highly developed healthcare infrastructure and the presence of many big pharmaceutical companies, which conduct a high number of testing for new drug development and disease diagnosis. Also, the rising preference for personalized medicines, which use biomarkers developed with the transcriptomic technologies will also fuel the transcriptomics market in the Americas over the forecast period.

Key questions answered in the report include

• What will the transcriptomics market size and growth rate be in 2020?
• What are the key factors driving the global transcriptomics market?
• What are the key market trends impacting the growth of the global transcriptomics market?
• What are the challenges to market growth?
• Who are the key vendors in the global transcriptomics market?
• What are the market opportunities and threats faced by the vendors in the global transcriptomics market?
• What are the trending factors influencing the market shares of the Americas, APAC, and EMEA?
• What are the key outcomes of the five forces analysis of the global transcriptomics market?

Technavio also offers customization on reports based on specific client requirement.

Related reports:

• Global DNA Sequencing Products Market 2016-2020
• Global Antibody Drug Conjugates Market 2016-2020
• Global Molecular Diagnostics Market 2016-2020
• Global Prenatal and Newborn Genetic Testing Market 2015-2019